0001209191-24-005009.txt : 20240320
0001209191-24-005009.hdr.sgml : 20240320
20240320183235
ACCESSION NUMBER: 0001209191-24-005009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240318
FILED AS OF DATE: 20240320
DATE AS OF CHANGE: 20240320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wilson Marc
CENTRAL INDEX KEY: 0001702265
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 24768935
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 263744114
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-450-6464
MAIL ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-03-18
0
0001658247
Crinetics Pharmaceuticals, Inc.
CRNX
0001702265
Wilson Marc
C/O CRINETICS PHARMACEUTICALS, INC.
6055 LUSK BOULEVARD
SAN DIEGO
CA
92121
0
1
0
0
CFO
1
Common Stock
2024-03-18
4
F
0
3983
38.14
D
117572
D
Common Stock
2024-03-19
4
S
0
6942
42.91
D
110630
D
Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on February 28, 2022 and March 1, 2023. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan.
The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $42.91 per share. The range of sales prices on the transaction date was $41.04 to $44.00 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
/s/ Marc Wilson
2024-03-20